APO Research
Talk to an analyst

APO RESEARCH · REPORT

Herpes Simplex Virus (HSV) Vaccines

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Herpes Simplex Virus (HSV) Vaccines Industry Growth and Trends Forecast to 2032

22 December 202572 pages

Choose your research edition.

Industry ResearchHerpes Simplex Virus (HSV) Vaccines Industry Research Report 2026112 pages · $2,950 USDIndustry Growth & TrendsGlobal Herpes Simplex Virus (HSV) Vaccines Industry Growth and Trends Forecast to 203272 pages · $3,450 USDMarket StructureGlobal Herpes Simplex Virus (HSV) Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032173 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Herpes Simplex Virus (HSV) Vaccines Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Herpes Simplex Virus (HSV) Vaccines Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Herpes Simplex Virus (HSV) Vaccines market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Herpes Simplex Virus (HSV) Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Herpes Simplex Virus (HSV) Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Herpes Simplex Virus (HSV) Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Herpes Simplex Virus (HSV) Vaccines include Sanofi, GlaxoSmithKline, Vical and Genocea Biosciences, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Herpes Simplex Virus (HSV) Vaccines market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Herpes Simplex Virus (HSV) Vaccines market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Herpes Simplex Virus (HSV) Vaccines market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Herpes Simplex Virus (HSV) Vaccines.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Herpes Simplex Virus (HSV) Vaccines market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Herpes Simplex Virus (HSV) Vaccines Market by Company

Sanofi

GlaxoSmithKline

Vical

Genocea Biosciences

Herpes Simplex Virus (HSV) Vaccines Segment by Type

VCL-HB01

HSV529

GEN-003

Others

Herpes Simplex Virus (HSV) Vaccines Segment by Application

HSV-1 (Oral Herpes)

HSV-2 (Genital Herpes)

Herpes Simplex Virus (HSV) Vaccines Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Herpes Simplex Virus (HSV) Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Herpes Simplex Virus (HSV) Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Herpes Simplex Virus (HSV) Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Herpes Simplex Virus (HSV) Vaccines manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Herpes Simplex Virus (HSV) Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of VCL-HB01 Table 2. Major Company of HSV529 Table 3. Major Company of GEN-003 Table 4. Major Company of Others Table 5. Global Herpes Simplex Virus (HSV) Vaccines Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Herpes Simplex Virus (HSV) Vaccines Sales by Type (2021-2026) & (k units) Table 7. Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share in Volume by Type (2021-2026) Table 8. Global Herpes Simplex Virus (HSV) Vaccines Sales by Type (2021-2026) & (US$ Million) Table 9. Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share in Value by Type (2021-2026) Table 10. Global Herpes Simplex Virus (HSV) Vaccines Price by Type (2021-2026) & (US$/unit) Table 11. Global Herpes Simplex Virus (HSV) Vaccines Sales by Type (2027-2032) & (k units) Table 12. Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share in Volume by Type (2027-2032) Table 13. Global Herpes Simplex Virus (HSV) Vaccines Sales by Type (2027-2032) & (US$ Million) Table 14. Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share in Value by Type (2027-2032) Table 15. Global Herpes Simplex Virus (HSV) Vaccines Price by Type (2027-2032) & (US$/unit) Table 16. North America Herpes Simplex Virus (HSV) Vaccines Sales by Type (2021-2026) & (k units) Table 17. North America Herpes Simplex Virus (HSV) Vaccines Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Herpes Simplex Virus (HSV) Vaccines Sales by Type (2021-2026) & (k units) Table 19. Europe Herpes Simplex Virus (HSV) Vaccines Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Herpes Simplex Virus (HSV) Vaccines Sales by Type (2021-2026) & (k units) Table 21. Asia-Pacific Herpes Simplex Virus (HSV) Vaccines Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Herpes Simplex Virus (HSV) Vaccines Sales by Type (2021-2026) & (k units) Table 23. Latin America Herpes Simplex Virus (HSV) Vaccines Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Herpes Simplex Virus (HSV) Vaccines Sales by Type (2021-2026) & (k units) Table 25. Middle East and Africa Herpes Simplex Virus (HSV) Vaccines Sales by Type (2021-2026) & (US$ Million) Table 26. Herpes Simplex Virus (HSV) Vaccines Industry Trends Table 27. Herpes Simplex Virus (HSV) Vaccines Industry Drivers Table 28. Herpes Simplex Virus (HSV) Vaccines Industry Opportunities and Challenges Table 29. Herpes Simplex Virus (HSV) Vaccines Industry Restraints Table 30. Global Herpes Simplex Virus (HSV) Vaccines Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Company (2021-2026) Table 32. Global Herpes Simplex Virus (HSV) Vaccines Sales by Company (2021-2026) & (k units) Table 33. Global Herpes Simplex Virus (HSV) Vaccines Sales Share by Company (2021-2026) Table 34. Global Herpes Simplex Virus (HSV) Vaccines Market Price by Company (2021-2026) & (US$/unit) Table 35. Global Herpes Simplex Virus (HSV) Vaccines Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Herpes Simplex Virus (HSV) Vaccines Major Company Production Sites and Headquarters Table 37. Global Herpes Simplex Virus (HSV) Vaccines Company, Product Type & Application Table 38. Global Herpes Simplex Virus (HSV) Vaccines Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Herpes Simplex Virus (HSV) Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Herpes Simplex Virus (HSV) Vaccines Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Herpes Simplex Virus (HSV) Vaccines Sales by Region (2021-2026) & (k units) Table 43. Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share in Volume by Region (2021-2026) Table 44. Global Herpes Simplex Virus (HSV) Vaccines Sales by Region (2021-2026) & (US$ Million) Table 45. Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share in Value by Region (2021-2026) Table 46. Global Herpes Simplex Virus (HSV) Vaccines Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 47. Global Herpes Simplex Virus (HSV) Vaccines Sales by Region (2027-2032) & (k units) Table 48. Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share in Volume by Region (2027-2032) Table 49. Global Herpes Simplex Virus (HSV) Vaccines Sales by Region (2027-2032) & (US$ Million) Table 50. Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share in Value by Region (2027-2032) Table 51. Global Herpes Simplex Virus (HSV) Vaccines Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 52. Global Herpes Simplex Virus (HSV) Vaccines Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Herpes Simplex Virus (HSV) Vaccines Sales by Application (2021-2026) & (k units) Table 54. Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share in Volume by Application (2021-2026) Table 55. Global Herpes Simplex Virus (HSV) Vaccines Sales by Application (2021-2026) & (US$ Million) Table 56. Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share in Value by Application (2021-2026) Table 57. Global Herpes Simplex Virus (HSV) Vaccines Price by Application (2021-2026) & (US$/unit) Table 58. Global Herpes Simplex Virus (HSV) Vaccines Sales by Application (2027-2032) & (k units) Table 59. Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share in Volume by Application (2027-2032) Table 60. Global Herpes Simplex Virus (HSV) Vaccines Sales by Application (2027-2032) & (US$ Million) Table 61. Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share in Value by Application (2027-2032) Table 62. Global Herpes Simplex Virus (HSV) Vaccines Price by Application (2027-2032) & (US$/unit) Table 63. North America Herpes Simplex Virus (HSV) Vaccines Sales by Application (2021-2026) & (k units) Table 64. North America Herpes Simplex Virus (HSV) Vaccines Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Herpes Simplex Virus (HSV) Vaccines Sales by Application (2021-2026) & (k units) Table 66. Europe Herpes Simplex Virus (HSV) Vaccines Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Herpes Simplex Virus (HSV) Vaccines Sales by Application (2021-2026) & (k units) Table 68. Asia-Pacific Herpes Simplex Virus (HSV) Vaccines Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Herpes Simplex Virus (HSV) Vaccines Sales by Application (2021-2026) & (k units) Table 70. Latin America Herpes Simplex Virus (HSV) Vaccines Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Herpes Simplex Virus (HSV) Vaccines Sales by Application (2021-2026) & (k units) Table 72. Middle East and Africa Herpes Simplex Virus (HSV) Vaccines Sales by Application (2021-2026) & (US$ Million) Table 73. Sanofi Company Information Table 74. Sanofi Business Overview Table 75. Sanofi Herpes Simplex Virus (HSV) Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 76. Sanofi Herpes Simplex Virus (HSV) Vaccines Product Portfolio Table 77. Sanofi Recent Development Table 78. GlaxoSmithKline Company Information Table 79. GlaxoSmithKline Business Overview Table 80. GlaxoSmithKline Herpes Simplex Virus (HSV) Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 81. GlaxoSmithKline Herpes Simplex Virus (HSV) Vaccines Product Portfolio Table 82. GlaxoSmithKline Recent Development Table 83. Vical Company Information Table 84. Vical Business Overview Table 85. Vical Herpes Simplex Virus (HSV) Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 86. Vical Herpes Simplex Virus (HSV) Vaccines Product Portfolio Table 87. Vical Recent Development Table 88. Genocea Biosciences Company Information Table 89. Genocea Biosciences Business Overview Table 90. Genocea Biosciences Herpes Simplex Virus (HSV) Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 91. Genocea Biosciences Herpes Simplex Virus (HSV) Vaccines Product Portfolio Table 92. Genocea Biosciences Recent Development Table 93. North America Herpes Simplex Virus (HSV) Vaccines Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 94. North America Herpes Simplex Virus (HSV) Vaccines Sales by Country (2021-2026) & (k units) Table 95. North America Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Country (2021-2026) Table 96. North America Herpes Simplex Virus (HSV) Vaccines Sales Forecast by Country (2027-2032) & (k units) Table 97. North America Herpes Simplex Virus (HSV) Vaccines Sales Market Share Forecast by Country (2027-2032) Table 98. North America Herpes Simplex Virus (HSV) Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 99. North America Herpes Simplex Virus (HSV) Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 100. North America Herpes Simplex Virus (HSV) Vaccines Market Share by Country (2021-2026) Table 101. North America Herpes Simplex Virus (HSV) Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 102. North America Herpes Simplex Virus (HSV) Vaccines Market Share Forecast by Country (2027-2032) Table 103. Europe Herpes Simplex Virus (HSV) Vaccines Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 104. Europe Herpes Simplex Virus (HSV) Vaccines Sales by Country (2021-2026) & (k units) Table 105. Europe Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Country (2021-2026) Table 106. Europe Herpes Simplex Virus (HSV) Vaccines Sales Forecast by Country (2027-2032) & (k units) Table 107. Europe Herpes Simplex Virus (HSV) Vaccines Sales Market Share Forecast by Country (2027-2032) Table 108. Europe Herpes Simplex Virus (HSV) Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 109. Europe Herpes Simplex Virus (HSV) Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 110. Europe Herpes Simplex Virus (HSV) Vaccines Market Share by Country (2021-2026) Table 111. Europe Herpes Simplex Virus (HSV) Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 112. Europe Herpes Simplex Virus (HSV) Vaccines Market Share Forecast by Country (2027-2032) Table 113. Asia-Pacific Herpes Simplex Virus (HSV) Vaccines Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 114. Asia-Pacific Herpes Simplex Virus (HSV) Vaccines Sales by Country (2021-2026) & (k units) Table 115. Asia-Pacific Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Country (2021-2026) Table 116. Asia-Pacific Herpes Simplex Virus (HSV) Vaccines Sales Forecast by Country (2027-2032) & (k units) Table 117. Asia-Pacific Herpes Simplex Virus (HSV) Vaccines Sales Market Share Forecast by Country (2027-2032) Table 118. Asia-Pacific Herpes Simplex Virus (HSV) Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 119. Asia-Pacific Herpes Simplex Virus (HSV) Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 120. Asia-Pacific Herpes Simplex Virus (HSV) Vaccines Market Share by Country (2021-2026) Table 121. Asia-Pacific Herpes Simplex Virus (HSV) Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 122. Asia-Pacific Herpes Simplex Virus (HSV) Vaccines Market Share Forecast by Country (2027-2032) Table 123. Latin America Herpes Simplex Virus (HSV) Vaccines Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 124. Latin America Herpes Simplex Virus (HSV) Vaccines Sales by Country (2021-2026) & (k units) Table 125. Latin America Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Country (2021-2026) Table 126. Latin America Herpes Simplex Virus (HSV) Vaccines Sales Forecast by Country (2027-2032) & (k units) Table 127. Latin America Herpes Simplex Virus (HSV) Vaccines Sales Market Share Forecast by Country (2027-2032) Table 128. Latin America Herpes Simplex Virus (HSV) Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. Latin America Herpes Simplex Virus (HSV) Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 130. Latin America Herpes Simplex Virus (HSV) Vaccines Market Share by Country (2021-2026) Table 131. Latin America Herpes Simplex Virus (HSV) Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. Latin America Herpes Simplex Virus (HSV) Vaccines Market Share Forecast by Country (2027-2032) Table 133. Middle East and Africa Herpes Simplex Virus (HSV) Vaccines Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 134. Middle East and Africa Herpes Simplex Virus (HSV) Vaccines Sales by Country (2021-2026) & (k units) Table 135. Middle East and Africa Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Country (2021-2026) Table 136. Middle East and Africa Herpes Simplex Virus (HSV) Vaccines Sales Forecast by Country (2027-2032) & (k units) Table 137. Middle East and Africa Herpes Simplex Virus (HSV) Vaccines Sales Market Share Forecast by Country (2027-2032) Table 138. Middle East and Africa Herpes Simplex Virus (HSV) Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Middle East and Africa Herpes Simplex Virus (HSV) Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 140. Middle East and Africa Herpes Simplex Virus (HSV) Vaccines Market Share by Country (2021-2026) Table 141. Middle East and Africa Herpes Simplex Virus (HSV) Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Middle East and Africa Herpes Simplex Virus (HSV) Vaccines Market Share Forecast by Country (2027-2032) Table 143. Key Raw Materials Table 144. Raw Materials Key Suppliers Table 145. Herpes Simplex Virus (HSV) Vaccines Distributors List Table 146. Herpes Simplex Virus (HSV) Vaccines Customers List Table 147. Research Programs/Design for This Report Table 148. Authors List of This Report Table 149. Secondary Sources Table 150. Primary Sources List of Figures Figure 1. Herpes Simplex Virus (HSV) Vaccines Image Figure 2. Global Herpes Simplex Virus (HSV) Vaccines Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Herpes Simplex Virus (HSV) Vaccines Market Size (2021-2032) & (US$ Million) Figure 4. Global Herpes Simplex Virus (HSV) Vaccines Sales (2021-2032) & (k units) Figure 5. VCL-HB01 Image Figure 6. Global VCL-HB01 Sales YoY Growth (2021-2032) & (k units) Figure 7. HSV529 Image Figure 8. Global HSV529 Sales YoY Growth (2021-2032) & (k units) Figure 9. GEN-003 Image Figure 10. Global GEN-003 Sales YoY Growth (2021-2032) & (k units) Figure 11. Others Image Figure 12. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 13. Global Herpes Simplex Virus (HSV) Vaccines Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Herpes Simplex Virus (HSV) Vaccines Market Share by Type 2025 VS 2032 Figure 15. North America Herpes Simplex Virus (HSV) Vaccines Sales Market Share in Volume by Type in 2025 Figure 16. North America Herpes Simplex Virus (HSV) Vaccines Sales Market Share in Value by Type in 2025 Figure 17. Europe Herpes Simplex Virus (HSV) Vaccines Sales Market Share in Volume by Type in 2025 Figure 18. Europe Herpes Simplex Virus (HSV) Vaccines Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Herpes Simplex Virus (HSV) Vaccines Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Herpes Simplex Virus (HSV) Vaccines Sales Market Share in Value by Type in 2025 Figure 21. Latin America Herpes Simplex Virus (HSV) Vaccines Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Herpes Simplex Virus (HSV) Vaccines Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Herpes Simplex Virus (HSV) Vaccines Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Herpes Simplex Virus (HSV) Vaccines Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Herpes Simplex Virus (HSV) Vaccines Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. HSV-1 (Oral Herpes) Image Figure 28. Global HSV-1 (Oral Herpes) Sales YoY Growth (2021-2032) & (k units) Figure 29. HSV-2 (Genital Herpes) Image Figure 30. Global HSV-2 (Genital Herpes) Sales YoY Growth (2021-2032) & (k units) Figure 31. Global Herpes Simplex Virus (HSV) Vaccines Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Herpes Simplex Virus (HSV) Vaccines Market Share by Application 2025 VS 2032 Figure 33. North America Herpes Simplex Virus (HSV) Vaccines Sales Market Share in Volume by Application in 2025 Figure 34. North America Herpes Simplex Virus (HSV) Vaccines Sales Market Share in Value by Application in 2025 Figure 35. Europe Herpes Simplex Virus (HSV) Vaccines Sales Market Share in Volume by Application in 2025 Figure 36. Europe Herpes Simplex Virus (HSV) Vaccines Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Herpes Simplex Virus (HSV) Vaccines Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Herpes Simplex Virus (HSV) Vaccines Sales Market Share in Value by Application in 2025 Figure 39. Latin America Herpes Simplex Virus (HSV) Vaccines Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Herpes Simplex Virus (HSV) Vaccines Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Herpes Simplex Virus (HSV) Vaccines Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Herpes Simplex Virus (HSV) Vaccines Sales Market Share in Value by Application in 2025 Figure 43. North America Herpes Simplex Virus (HSV) Vaccines Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 44. North America Herpes Simplex Virus (HSV) Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Herpes Simplex Virus (HSV) Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Herpes Simplex Virus (HSV) Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Herpes Simplex Virus (HSV) Vaccines Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 48. Europe Herpes Simplex Virus (HSV) Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Herpes Simplex Virus (HSV) Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Herpes Simplex Virus (HSV) Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Herpes Simplex Virus (HSV) Vaccines Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 52. Asia-Pacific Herpes Simplex Virus (HSV) Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Herpes Simplex Virus (HSV) Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Herpes Simplex Virus (HSV) Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Herpes Simplex Virus (HSV) Vaccines Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 56. Latin America Herpes Simplex Virus (HSV) Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Herpes Simplex Virus (HSV) Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Herpes Simplex Virus (HSV) Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Herpes Simplex Virus (HSV) Vaccines Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 60. Middle East and Africa Herpes Simplex Virus (HSV) Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Herpes Simplex Virus (HSV) Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Herpes Simplex Virus (HSV) Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Herpes Simplex Virus (HSV) Vaccines Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Herpes Simplex Virus (HSV) Vaccines Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • VCL-HB01
  • HSV529
  • GEN-003
  • Others
Applications
  • HSV-1 (Oral Herpes)
  • HSV-2 (Genital Herpes)
Companies covered
  • Sanofi
  • GlaxoSmithKline
  • Vical
  • Genocea Biosciences

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Herpes Simplex Virus (HSV) Vaccines Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Herpes Simplex Virus (HSV) Vaccines Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Herpes Simplex Virus (HSV) Vaccines Market by Type
  6. 1.3.1 VCL-HB01
  7. 1.3.2 HSV529
  8. 1.3.3 GEN-003
  9. 1.3.4 Others
  10. 1.4 Global Herpes Simplex Virus (HSV) Vaccines Market Size by Type
  11. 1.4.1 Global Herpes Simplex Virus (HSV) Vaccines Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Herpes Simplex Virus (HSV) Vaccines Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Herpes Simplex Virus (HSV) Vaccines Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Herpes Simplex Virus (HSV) Vaccines Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Herpes Simplex Virus (HSV) Vaccines Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Herpes Simplex Virus (HSV) Vaccines Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Herpes Simplex Virus (HSV) Vaccines Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Herpes Simplex Virus (HSV) Vaccines Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Herpes Simplex Virus (HSV) Vaccines Industry Trends
  2. 2.2 Herpes Simplex Virus (HSV) Vaccines Industry Drivers
  3. 2.3 Herpes Simplex Virus (HSV) Vaccines Industry Opportunities and Challenges
  4. 2.4 Herpes Simplex Virus (HSV) Vaccines Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Herpes Simplex Virus (HSV) Vaccines Revenue (2021-2026)
  2. 3.2 Global Top Players by Herpes Simplex Virus (HSV) Vaccines Sales (2021-2026)
  3. 3.3 Global Top Players by Herpes Simplex Virus (HSV) Vaccines Price (2021-2026)
  4. 3.4 Global Herpes Simplex Virus (HSV) Vaccines Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Herpes Simplex Virus (HSV) Vaccines Major Company Production Sites & Headquarters
  6. 3.6 Global Herpes Simplex Virus (HSV) Vaccines Company, Product Type & Application
  7. 3.7 Global Herpes Simplex Virus (HSV) Vaccines Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Herpes Simplex Virus (HSV) Vaccines Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Herpes Simplex Virus (HSV) Vaccines Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Herpes Simplex Virus (HSV) Vaccines Tier 1, Tier 2, and Tier 3
4 Herpes Simplex Virus (HSV) Vaccines Regional Status and Outlook
  1. 4.1 Global Herpes Simplex Virus (HSV) Vaccines Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Herpes Simplex Virus (HSV) Vaccines Historic Market Size by Region
  3. 4.2.1 Global Herpes Simplex Virus (HSV) Vaccines Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Herpes Simplex Virus (HSV) Vaccines Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Herpes Simplex Virus (HSV) Vaccines Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Herpes Simplex Virus (HSV) Vaccines Forecasted Market Size by Region
  7. 4.3.1 Global Herpes Simplex Virus (HSV) Vaccines Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Herpes Simplex Virus (HSV) Vaccines Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Herpes Simplex Virus (HSV) Vaccines Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Herpes Simplex Virus (HSV) Vaccines by Application
  1. 5.1 Herpes Simplex Virus (HSV) Vaccines Market by Application
  2. 5.1.1 HSV-1 (Oral Herpes)
  3. 5.1.2 HSV-2 (Genital Herpes)
  4. 5.2 Global Herpes Simplex Virus (HSV) Vaccines Market Size by Application
  5. 5.2.1 Global Herpes Simplex Virus (HSV) Vaccines Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Herpes Simplex Virus (HSV) Vaccines Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Herpes Simplex Virus (HSV) Vaccines Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Herpes Simplex Virus (HSV) Vaccines Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Herpes Simplex Virus (HSV) Vaccines Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Herpes Simplex Virus (HSV) Vaccines Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Herpes Simplex Virus (HSV) Vaccines Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Herpes Simplex Virus (HSV) Vaccines Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Sanofi
  2. 6.1.1 Sanofi Company Information
  3. 6.1.2 Sanofi Business Overview
  4. 6.1.3 Sanofi Herpes Simplex Virus (HSV) Vaccines Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Sanofi Herpes Simplex Virus (HSV) Vaccines Product Portfolio
  6. 6.1.5 Sanofi Recent Developments
  7. 6.2 GlaxoSmithKline
  8. 6.2.1 GlaxoSmithKline Company Information
  9. 6.2.2 GlaxoSmithKline Business Overview
  10. 6.2.3 GlaxoSmithKline Herpes Simplex Virus (HSV) Vaccines Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 GlaxoSmithKline Herpes Simplex Virus (HSV) Vaccines Product Portfolio
  12. 6.2.5 GlaxoSmithKline Recent Developments
  13. 6.3 Vical
  14. 6.3.1 Vical Company Information
  15. 6.3.2 Vical Business Overview
  16. 6.3.3 Vical Herpes Simplex Virus (HSV) Vaccines Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Vical Herpes Simplex Virus (HSV) Vaccines Product Portfolio
  18. 6.3.5 Vical Recent Developments
  19. 6.4 Genocea Biosciences
  20. 6.4.1 Genocea Biosciences Company Information
  21. 6.4.2 Genocea Biosciences Business Overview
  22. 6.4.3 Genocea Biosciences Herpes Simplex Virus (HSV) Vaccines Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Genocea Biosciences Herpes Simplex Virus (HSV) Vaccines Product Portfolio
  24. 6.4.5 Genocea Biosciences Recent Developments
7 North America by Country
  1. 7.1 North America Herpes Simplex Virus (HSV) Vaccines Sales by Country
  2. 7.1.1 North America Herpes Simplex Virus (HSV) Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Herpes Simplex Virus (HSV) Vaccines Sales by Country (2021-2026)
  4. 7.1.3 North America Herpes Simplex Virus (HSV) Vaccines Sales Forecast by Country (2027-2032)
  5. 7.2 North America Herpes Simplex Virus (HSV) Vaccines Market Size by Country
  6. 7.2.1 North America Herpes Simplex Virus (HSV) Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Herpes Simplex Virus (HSV) Vaccines Market Size by Country (2021-2026)
  8. 7.2.3 North America Herpes Simplex Virus (HSV) Vaccines Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Herpes Simplex Virus (HSV) Vaccines Sales by Country
  2. 8.1.1 Europe Herpes Simplex Virus (HSV) Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Herpes Simplex Virus (HSV) Vaccines Sales by Country (2021-2026)
  4. 8.1.3 Europe Herpes Simplex Virus (HSV) Vaccines Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Herpes Simplex Virus (HSV) Vaccines Market Size by Country
  6. 8.2.1 Europe Herpes Simplex Virus (HSV) Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Herpes Simplex Virus (HSV) Vaccines Market Size by Country (2021-2026)
  8. 8.2.3 Europe Herpes Simplex Virus (HSV) Vaccines Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Herpes Simplex Virus (HSV) Vaccines Sales by Country
  2. 9.1.1 Asia-Pacific Herpes Simplex Virus (HSV) Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Herpes Simplex Virus (HSV) Vaccines Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Herpes Simplex Virus (HSV) Vaccines Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Herpes Simplex Virus (HSV) Vaccines Market Size by Country
  6. 9.2.1 Asia-Pacific Herpes Simplex Virus (HSV) Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Herpes Simplex Virus (HSV) Vaccines Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Herpes Simplex Virus (HSV) Vaccines Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Herpes Simplex Virus (HSV) Vaccines Sales by Country
  2. 10.1.1 South America Herpes Simplex Virus (HSV) Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Herpes Simplex Virus (HSV) Vaccines Sales by Country (2021-2026)
  4. 10.1.3 South America Herpes Simplex Virus (HSV) Vaccines Sales Forecast by Country (2027-2032)
  5. 10.2 South America Herpes Simplex Virus (HSV) Vaccines Market Size by Country
  6. 10.2.1 South America Herpes Simplex Virus (HSV) Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Herpes Simplex Virus (HSV) Vaccines Market Size by Country (2021-2026)
  8. 10.2.3 South America Herpes Simplex Virus (HSV) Vaccines Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Herpes Simplex Virus (HSV) Vaccines Sales by Country
  2. 11.1.1 Middle East and Africa Herpes Simplex Virus (HSV) Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Herpes Simplex Virus (HSV) Vaccines Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Herpes Simplex Virus (HSV) Vaccines Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Herpes Simplex Virus (HSV) Vaccines Market Size by Country
  6. 11.2.1 Middle East and Africa Herpes Simplex Virus (HSV) Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Herpes Simplex Virus (HSV) Vaccines Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Herpes Simplex Virus (HSV) Vaccines Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Herpes Simplex Virus (HSV) Vaccines Value Chain Analysis
  2. 12.1.1 Herpes Simplex Virus (HSV) Vaccines Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Herpes Simplex Virus (HSV) Vaccines Production Mode & Process
  7. 12.2 Herpes Simplex Virus (HSV) Vaccines Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Herpes Simplex Virus (HSV) Vaccines Distributors
  10. 12.2.3 Herpes Simplex Virus (HSV) Vaccines Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst